부가기능
Triple Antiplatelet Therapy During Percutaneous Coronary Intervention Is Associated With Improved Outcomes Including One-Year Survival: Results From the Do Tirofiban and ReoPro Give Similar Efficacy Outcome Trial (TARGET)/
기사 상세정보
서평
서평등록 중 오류가 발생하였습니다. 재시도 하십시오.